I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Pederson, Susan
105
results:
Search for persons
X
Format
Online (105)
Mediatypes
E-Books (1)
Articles (Online) (60)
Bookchapter (Online) (3)
OpenAccess-fulltext (41)
Sorted by: Relevance
Sorted by: Year
?
1
Varied Patterns of Decay of Intact Human Immunodeficiency V..:
Gandhi, Rajesh T
;
Bosch, Ronald J
;
Mar, Hanna
...
The Journal of Infectious Diseases. 227 (2023) 12 - p. 1376-1380 , 2023
Link:
https://doi.org/10.1093/..
?
2
Tolerability of eptinezumab in overweight, obese or type 1 ..:
Baker, Brian
;
Schaeffler, Barbara
;
Hirman, Joe
...
Endocrinology, Diabetes & Metabolism. 4 (2021) 2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
3
Clinical Immunogenicity Evaluation of Eptinezumab, a Therap..:
Pederson, Susan
;
Biondi, David M.
;
Allan, Brent
...
Frontiers in Immunology. 12 (2021) - p. , 2021
Link:
https://doi.org/10.3389/..
?
4
Corrigendum to "Eptinezumab for the Prevention of Episodic ..:
Smith, Timothy R.
;
Janelidze, Marina
;
Chakhava, George
...
Clinical Therapeutics. 43 (2021) 4 - p. 791 , 2021
Link:
https://doi.org/10.1016/..
?
5
Eptinezumab for the prevention of chronic migraine: efficac..:
Silberstein, Stephen
;
Diamond, Merle
;
Hindiyeh, Nada A.
...
The Journal of Headache and Pain. 21 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1186/..
?
6
Selective Decay of Intact HIV-1 Proviral DNA on Antiretrovi..:
Gandhi, Rajesh T
;
Cyktor, Joshua C
;
Bosch, Ronald J
...
The Journal of Infectious Diseases. 223 (2020) 2 - p. 225-233 , 2020
Link:
https://doi.org/10.1093/..
?
7
Eptinezumab for the Prevention of Episodic Migraine: Sustai..:
Smith, Timothy R.
;
Janelidze, Marina
;
Chakhava, George
...
Clinical Therapeutics. 42 (2020) 12 - p. 2254-2265.e3 , 2020
Link:
https://doi.org/10.1016/..
?
8
Efficacy and safety of eptinezumab in patients with chronic..:
Lipton, Richard B.
;
Goadsby, Peter J.
;
Smith, Jeff
...
Neurology. 94 (2020) 13 - p. , 2020
Link:
https://doi.org/10.1212/..
?
9
Population pharmacokinetic and exposure‐response analysis o..:
Baker, Brian
;
Schaeffler, Barbara
;
Beliveau, Martin
...
Pharmacology Research & Perspectives. 8 (2020) 2 - p. , 2020
Link:
https://doi.org/10.1002/..
?
10
Differences in Exposure Between Intravenously (IV) Administ..:
Baker, Brian
;
Beliveau, Martin
;
Pederson, Susan
.
Neurology. 94 (2020) 15_supplement - p. , 2020
Link:
https://doi.org/10.1212/..
?
11
Eptinezumab in episodic migraine: A randomized, double-blin..:
Ashina, Messoud
;
Saper, Joel
;
Cady, Roger
...
Cephalalgia. 40 (2020) 3 - p. 241-254 , 2020
Link:
https://doi.org/10.1177/..
?
12
Improving user satisfaction via a case‐enhanced e‐learning ..:
Jeong Kim, Hye
;
Pederson, Susan
;
Baldwin, Moira
Education + Training. 54 (2012) 2/3 - p. 204-218 , 2012
Link:
https://doi.org/10.1108/..
?
13
B-lymphocyte stimulator/a proliferation-inducing ligand het..:
Dillon, Stacey R
;
Harder, Brandon
;
Lewis, Kenneth B
...
Arthritis Research & Therapy. 12 (2010) 2 - p. R48 , 2010
Link:
https://doi.org/10.1186/..
?
14
Preclinical safety of recombinant human thrombin:
Heffernan, Jane K.
;
Ponce, Rafael A.
;
Zuckerman, Linda A.
...
Regulatory Toxicology and Pharmacology. 47 (2007) 1 - p. 48-58 , 2007
Link:
https://doi.org/10.1016/..
?
15
Preclinical Safety and Pharmacokinetics of Recombinant Huma..:
Ponce, Rafael A.
;
Visich, Jennifer E.
;
Heffernan, Jane K.
...
Toxicologic Pathology. 33 (2005) 4 - p. 495-506 , 2005
Link:
https://doi.org/10.1080/..
1-15